Approval · Notice of Compliance 13255 · 2012
TEVA-NABILONE: Notice of Compliance 13255
Issued May 1, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13255
- Date
- May 1, 2012
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antiemetic
- Canadian reference product
- CESAMAET
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-NABILONE | 02384884 | Marketed |
| TEVA-NABILONE | 02384892 | Marketed |